Primary Job Title CEO and Co-Founder Primary Organization January Therapeutics
Location Greater San Diego Area, California, United States Regions West Coast, Western US Gender Male Also Known As Robin M. Jackman
LinkedIn View on LinkedIn
Robin Jackman, Ph.D., is CEO and a co-founder of January Therapeutics. He has over 20 years of experience at the intersection of medicine, science, and business. Previously, he led the venture-backed orphan drug startup Zacharon Pharmaceuticals from discovery stage through large pharma partnerships and an eventual sale to BioMarin. Prior to that,
he headed the oncology business division at Vical, advancing 2 immuno-oncology biologics through a Phase 1 clinical trial and a Phase 3, worldwide 125-site clinical trial respectively. Robin also led a biopharma company in critical care medicine from concept-stage through full CMC development, IND filings and into Phase 2 clinical efficacy trials. Dr. Jackman is expert at building and advancing new programs and platforms; drug discovery to clinical development and partnerships. In his career he has completed over $10 billion in deal value through 80+ partnerships, financings, and company sales. Robin holds graduate degrees from Harvard Medical School and Harvard University, and an undergraduate degree from Stanford University.
